Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Plos Genetics|September 7, 2018
The conserved protective cyclic AMP-phosphodiesterase function PDE4B is expressed in the adenoma and adjacent normal colonic epithelium of mammals and silenced in colorectal cancerJennifer K Pleiman, Amy A Irving, Zhishi Wang, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 21, 2016
The effects of tumor treating fields and temozolomide in MGMT expressing and non-expressing patient-derived glioblastoma cellsPaul A Clark, Jordan T Gaal, Joslyn K Strebe, et al.
Cancer|July 27, 2022
A randomized phase 2 trial of nivolumab, gemcitabine, and cisplatin or nivolumab and ipilimumab in previously untreated advanced biliary cancer: BilT-01Vaibhav Sahai, Kent A Griffith, Muhammad S Beg, et al.
Gastroenterology Report|February 21, 2025
Micro-environmental changes indicate potential for subclinical intestinal tissue damage in early-age-onset colorectal cancer patientsSean G Kraus, Katherine A Johnson, Philip B Emmerich, et al.
Current Treatment Options in Oncology|April 25, 2020
Human Colon Organoids and Other Laboratory Strategies to Enhance Patient Treatment SelectionKatherine A Johnson, Rebecca A DeStefanis, Philip B Emmerich, et al.
Cancers|April 30, 2021
Autofluorescence Imaging of Treatment Response in Neuroendocrine Tumor OrganoidsAmani A Gillette, Christopher P Babiarz, Ava R VanDommelen, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 4, 2022
Clinical utility of a regional precision medicine molecular tumor board and challenges to implementationKeng Hee Peh, Daniel J Przybylski, Michael J Fallon, et al.
Therapeutic Advances in Medical Oncology|September 2, 2015
Precision medicine in colorectal cancer: the molecular profile alters treatment strategiesNguyen H Tran, Ludimila L Cavalcante, Sam J Lubner, et al.
Clinical Breast Cancer|April 3, 2020
Acquisition of Cabozantinib-Sensitive MET D1228N Mutation During Progression on Crizotinib in MET-Amplified Triple-Negative Breast CancerBenjamin M Parsons, David R Meier, Craig S Richmond, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2018
Activating Mutations in Pik3ca Contribute to Anal Carcinogenesis in the Presence or Absence of HPV-16 OncogenesMyeong-Kyun Shin, Susan Payne, Andrea Bilger, et al.
Pageof 8